BSENHC Foods Ltd· Food ProductsHighNeutral
Announced Mon, 9 Feb, 2026 · 12:40 IST

Results- Financial Results December 31, 2025

Revenue Growth 20pctEbitda Margin CompressionPat Growth 25pctResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹0.80
prior close
₹0.79
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+2.6%-2.6% vs market
Other Food Products peers, median of 26sector+0.4%-0.4% vs sector

On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 0.4 pts less than its Other Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0+2.6-2.6+0.4-0.4
Next day
-1.3+3.6-4.9-0.5-0.8
2d
-1.3+3.1-4.3+1.7-2.9
3d
-2.5+2.6-5.1+1.5-4.0
4d
-3.8+1.1-4.8-0.7-3.1
5d
-3.8+0.3-4.1-1.3-2.4
1w
-6.3+1.6-7.9-0.5-5.8
15d
+3.8-3.9+7.7-3.2+6.9
1m
+1.3-8.1+9.4-4.7+6.0
2m
+2.5-3.1+5.6-6.0+8.5
3m
+23.8+9.2+14.6+1.2+22.5
UpDownMarket · Nifty Microcap 250Sector · Other Food Products peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NHC Foods reported strong top-line growth for Q3 FY26 with standalone revenue from operations rising about 59% YoY to Rs 11,698.09 lakhs (vs Rs 7,336.53 lakhs in Q3 FY25) and 9M revenue up about 60% to Rs 33,069.71 lakhs. On a consolidated basis, Q3 revenue was Rs 12,919.04 lakhs and 9M revenue was Rs 34,290.66 lakhs. However, standalone PAT fell to Rs 187.51 lakhs in Q3 from Rs 209.35 lakhs YoY, and 9M PAT declined to Rs 489.02 lakhs from Rs 579.66 lakhs, showing margin pressure as finance costs jumped sharply (9M finance cost rose to Rs 360.63 lakhs vs Rs 252 lakhs). Consolidated Q3 PAT did grow about 27% YoY to Rs 264.65 lakhs, helped by the UAE subsidiary. The board also approved raising up to USD 27 million via equity/debt instruments, increasing the borrowing limit to Rs 500 crore, and a postal ballot for shareholder approvals.

Likely market impact

Strong revenue growth is positive, but the drop in standalone profits and rising finance costs suggest margin compression and higher leverage, which may concern shareholders. The large fund-raising plan and increase in the promoter/MD stake (from 3.82% to 13.83%) could lead to dilution and is worth watching for the stock price.